Jackie Hunter
Chief Executive Officer at BENEVOLENTBIO; and CE of Clinical and Strategic Partnerships at BENEVOLENTAI
Meet Jackie Hunter
BenevolentAI is using artificial intelligence technology to transform the way medicines are discovered and brought to market. Jackie Hunter has extensive experience in the industry and was previously responsible for developing GSK’s external innovation strategy, as well as the concept of the Stevenage Bioscience Catalyst. In 2010, she was awarded a CBE in the Queen’s Birthday Honours list in the UK for Services to the Pharmaceutical Industry.